This inventor holds 1 USPTO granted patent. Top assignee: Princeton University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bahar Javdan: Innovator in Drug Metabolism Assessment
Introduction
Bahar Javdan is an accomplished inventor based in Fort Lee, NJ (US). She has made significant contributions to the field of drug metabolism through her innovative research and development efforts. Her work focuses on understanding the impact of the human gut microbiome on drug metabolism, which is crucial for personalized medicine.
Latest Patents
Bahar Javdan holds a patent for a groundbreaking invention titled "Quantitative screen for the assessment of inter-individual variability in drug metabolism by the human gut microbiome." This patent introduces the MDMQ-Screen, a quantitative tool designed to assess microbiome-derived drug metabolism. The MDMQ-Screen measures and explains inter-individual variability in drug metabolism, providing essential insights into potential toxic effects of administered drugs and variability in therapeutic responses among individuals.
Career Highlights
Bahar Javdan is affiliated with Princeton University, where she continues her research and development in drug metabolism. Her work is instrumental in explaining unexplained variability in drug response and toxicity of existing medications. The MDMQ-Screen is also poised to play a vital role in future drug development pipelines, aiding in the design and interpretation of clinical trials.
Collaborations
Bahar collaborates with esteemed colleagues, including Mohamed Abou Donia and Jaime Lopez. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field of drug metabolism.
Conclusion
Bahar Javdan's innovative work in drug metabolism assessment through the MDMQ-Screen represents a significant advancement in personalized medicine. Her contributions are paving the way for improved therapeutic outcomes and a better understanding of drug interactions with the human microbiome.